Treatable traits approach towards COPD management for busy pulmonologists
With the GOLD 2020 strategy document, the focus on utilization of the treatable traits approach of symptoms and exacerbations for COPD management continues to gain...
A New Direction in PAH: A Potential Therapy for Rebalancing BMPR2 Signaling
Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.
Chronic Rhinosinusitis With Nasal Polyps: From Pathophysiology to Management
An informative, non-CME, disease state virtual presentation focusing on chronic rhinosinusitis with nasal polyps (CRSwNP).
ACCURACY IS EVERYTHING: RECENT CLINICAL EVIDENCE IN NAVIGATION
A static image can make nodule biopsies using lung navigation challenging. You need confidence throughout the procedure to know you are on target. Learn about the...
The Current State of OFEV® (nintedanib): A Treatment Journey
The program will review background information followed by the most up-to-date data supporting the efficacy and safety of OFEV. The presentation is sponsored by...
COPD Management in the time of COVID-19 & New Real World Data on Inhaler Choice
Has COVID-19 impacted the way you treat your COPD patients?